SVP, Chief Medical Officer, Internal Medicine, Pfizer Innovative Health
Chief Science Officer, SENS Research Foundation
Director of Health Research and Innovation, Basque Ministry for Health
Chairman Cancer Research UK
Interim Executive Chair of Innovate UK
Senior Vice President, Clinical Pharmacology and Safety Sciences, AstraZeneca’s BioPharmaceuticals R&D unit
The meeting place for leading stakeholders driving the next generation of innovative healthcare technology
Chief Medical Officer, AstraZeneca
Managing Director-Healthcare Ventures, Ziff Capital Partners
President and CEO, Kintai Therapeutics
President and CEO,GE Healthcare Life Sciences
Partner, Apollo Ventures
Co-founder of Amadeus Capital Partners
Senior News Editor for Nature Biotechnology
Member of Parliament for Cambridge
Chairman, Health Horizons
VP, Head of Genome Analytics & Informatics, AstraZeneca Centre for Genomics Research (CGR)
Vice-President of the Discovery Biology department at AstraZeneca
Director and Board member, CIBBIM-Nanomedicine
Cancer Research UK
Senior Director External Innovation, Eli Lilly and Company
Director of Health and AI Partnerships (Academic) at Microsoft Research
VP, Corporate and Communications, Oxford Nanopore
founder and CSO, BrainVectis
Vice President of Innovation, PatientsLikeMe
Senior Director, Johnson & Johnson Innovation
Team Leader at AstraZeneca in Advanced Drug Delivery
Dean of the Warwick Medical School
Director, AstraZeneca
Chief Clinical Officer, Eastern Academic Health Science Network
Professor of Medicine Emeritus and Director of Research, University of Cambridge
Head of “Structural Biology in Dementia” at the German Center for Neurodegenerative Diseases (DZNE)
Thorax Institute Clinical Director
Co-Founder and CEO, Astex Pharmaceuticals
General of the International Iberian Nanotechnology Laboratory
CEO, Virtual Bodyworks
Executive Director and Founder, IVRHA
Clinical Sciences Group Lead, Pfizer
Sports Scientist, Athletic Bilbao
CEO and Co-Founder, Cleanbox Technology
Professor of Economics, RMIT University
Founder & Managing partner 4BIO Capital Partners
Bespoke Drug Development Solutions,Biosynetix Ltd.
Co-founder & Chief Scientific Officer, Microbiotica
Executive Vice President and Chief R&D Officer, Sosei Heptares
Associate Professor of Environmental Epigenetics, Harvard TH Chan School of Public Health
Co-founder, Cure & Action for Tay-Sachs (CATS) Foundation
Personal Chair of Chemical and Structural Biology, School of Life Sciences, University of Dundee
Co-founder and CEO, Healx Ltd
Professor of Health Services Research
Head, Cambridge Innovation Hub, Roche Pharma Partnering
CEO, Findacure
Deputy Director of the MRC UKRMP Regen Med Hub
Chief Executive Officer. Celixir
CEO & Co-Founder, Innoplexus
Population Health, Worldwide Healthcare Lead, HP, Inc.
Healthy Ageing Programme Development Manager; Ageing Better
Professor, Institute of Medical Sciences, University of Oslo; Infrastructure Operations Director, EU Human Brain Project
CEO, o2h Ventures
Director, Clinical Practice Research Datalink (CPRD)
CEO, Endomag
Founder & Chairman, aPODD Foundation; Co-founder and Chief Operating Officer, Oncoheroes Biosciences Inc
Deputy Director, Big Data Institute; Director, Health Data Research UK Oxford
Sr. Director of Regulatory Affairs & Policy for Europe, AstraZeneca R&D
Co-founder and CEO, Senolytic Therapeutics Inc.
Chief Business Officer, Dementia Discovery Fund
Operating Partner, Cambridge Innovation Capital
CEO, Magstim Group
Head of Chemistry, GTN
Head of Cancer Research UK Laboratories, Gurdon Institute
Founder & CEO, Shift Bioscience
Founder & CEO, Insilico Medicine
Co-Founder, FundamentalVR
Senior Investment Director, Merck Ventures
Global Life Sciences Industry Leader, IBM
Head of Healthcare CEMEA at DNB
Director, Quadram Institute
Venture Capital Investor
Professor of Physical Chemistry and Biophysics in the Department of Chemistry of Cambridge
Assistant Professor, Mayo Clinic, Florida
Professor of Cancer Biology at the University of Cambridge
CEO, Founder at Prellis Biologics, Inc.
Professor of Pharmacology and Regulatory Science at the Universidade de Lisboa, Faculty of Pharmacy, and head of the Department of Pharmacological Sciences
Professor of Management Science and Operations; Deloitte Chair in Innovation and Entrepreneurship
Director, Cambridge Science Park
Chief Executive, Health Enterprise East
Co-founder and Chief Executive Officer, HairClone
Cancer Research UK Professor, University of Manchester and Christie Hospital
Professor of Pharmacology, King's College London
CEO and Co-founder, Lifebit
Senior Director, Neuroscience External Innovation, Johnson & Johnson Innovation
Co-founder & CEO, Cambridge Cancer Genomics
Chief Commercial Officer, Genomics England
CEO, Start Codon
Chief Executive Officer, PhoreMost Ltd.
Director, Cambridge Academy of Therapeutic Sciences (CATS); Professor Emeritus of Biotechnology at the University of Cambridge
Founder/Director, AgeCurve Limited
President, The European Institute for Innovation through Health Data (i~HD)
Chief Business & Strategy Officer, Catapult Medicines Descovery
Chief Executive, Daphne Jackson Trust
Alacris Theranostics GmbH
European Commission
Co-founder and CEO, Transparency Life Sciences
Director & ProfessorMing Wai Lau Center for Reparative Medicine, HKKarolinska Institute, Sweden
CEO, Novoheart
Master, St Catharine’s College; Professor of Nanotechnology, Head of the Nanoscience Centre, Deputy Vice-Chancellor, Special Adviser to the Vice-Chancellor on China, and Director of the Maxwell Centre, University of Cambridge
CEO at Cellvax
Chief Executive of NorthWest EHealth
Investment Director, Co-High Venture Capital
Understanding Patient Data Lead, Wellcome Trust
Chief Technology Officer, GE Healthcare Life Sciences
Director of MedTech Consulting, Health Enterprise East
Co-founder, Food Academy
Site Director, AstraZeneca Gothenburg
D.Phil. MBA, Head of Emerging Innovations
Coordinator, medConfidential
Chief Business Officer, BodyWorks
Innovation Communications Leader, Johnson & Johnson Innovation
Managing Partner, Abingworth LLP
Consumer Products safety, European Commission
CEO, Wren Therapeutics
Associate Fellow of Green Templeton College
Lecturer of Clinical Informatics in the Department of Medicine at the University of Cambridge.
Analyst, Forbion
Fellow, Royal College of Obstetricians & Gynaecologists
CEO, Ontoforce
Editor, Cambridge Independent, and editorial director, Iliffe Media
Global Head of Neurodegeneration and the Alzheimer's Disease and Neurodegeneration Franchise Head in Product Development, Neuroscience at Roche Pharmaceutical
Research Scientific Director, Servier
CEO and Founder, Nell Health
Partner, Delin Ventures
Senior Fellow, The Health Foundation
Head of Adaptive Tumor Immunity and Principal Scientist in Cancer Immunology Discovery Research, Genentech
Vice President of Scientific Learning, AstraZeneca
Chair, Stevenage Bioscience Catalyst
Deals Manager - Entrepreneurial and Venture Capital Business at NextLevel.
Medical Physicist, Araba Integrated Health Organization
Investment Director, Arix
Executive Director, Head of Early-stage Partnering, Astellas Innovation Management
Senior Lecturer in Neonatal Medicine, Imperial College London
,Chief Medical Officer & Co-Founder, Turbine
Director, Cambridge Corporate Affairs
Director, Barclays Ventures
Commercial & Innovation Programme, UCLPartners
CEO, LifeArc
